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Sex Med 2Introduction: The sexually related personal distress becomes an obligation for the diagnosis of female sexual
dysfunction (FSD). The Female Sexual Distress Scale-Revised (FSDS-R) was developed, extensively validated,
and is among the most widely used tools to measure distress associated with impaired sexual function.
Aim: This study aims to develop a Turkish version of the FSDS-R, to evaluate its psychometric reliability and
validity, and to estimate the optimal cutoff score that corresponds best to the clinical diagnosis of sexual
dysfunction.
Methods: Ninety-ﬁve participants were diagnosed with female sexual interest and arousal disorder (FSIAD), 25
participants were diagnosed with another FSD, and 128 participants were healthy. Alpha coefﬁcients (a) were
used as an indicator of internal consistency. Testeretest reliability over a 2-week period was estimated using
intraclass correlation coefﬁcients (ICCs). Correlation analysis conducted between the FSDS-R total score, the
Female Sexual Function Index subscale, and total score was examined for convergent validity. Discriminant
validity was assessed by comparing mean scores of the FSD and control groups in a between-groups analysis of
variance. Receiver operating characteristic analysis was performed to determine optimal cutoff values of the
Turkish version of Female Sexual Distress Scale-Revised (Tr-FSDS-R).
Main Outcomes Measures: Sexuality-related distress measured by the Turkish version of the FSDS-R.
Results: Internal consistencies of the FSDS-R across the two assessments point for the three groups of women
ranged from a ¼ 0.87 to a ¼ 0.99. ICCs ranged from 0.92 to 0.94 for baseline and day 15 for FSIAD, other
FSD, and no FSD groups. One-factor unidimensional model explained 85.7% of the total variance of the Tr-
FSDS-R items. The optimal cutoff score was found to be >11.5 to provide optimal sensitivity (97.9%) and
speciﬁcity (83.2%). Signiﬁcant differences in the FSDS-R scores were found between healthy women, women
with hypoactive sexual desire disorder, and women with other types of FSD.
Conclusion: The Turkish version of FSDS-R is a valid, reliable tool with well discriminative and psychometric
validity for use in the Turkish female population and can be used as a screening questionnaire for females with
sexual interest/arousal disorder. The score of 11.5 was proposed as a cutoff to detect the presence of sexually
related personal distress in Turkish women with FSD.
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Female sexual dysfunction (FSD) is a term used to describe
any problem that may be encountered in the interruption of
normal sexual functioning, such as low desire or interest,
diminished arousal, orgasmic difﬁculties, and dyspareunia. FSD
is a complex and multidimensional problem resulting from
physical, social, and psychological factors such as culture, reli-
gion, age, mental health, and interpersonal relations. Its inci-
dence increases with age, and up to 75% prevalence has beene43
e44 Aydın et alreported, with estimates differing across populations and
cultures.1e5 The few studies in Turkey have reported that FSD
may affect up to 46.9% of women.6 The FSD prevalence by age
groups were 22% for those 20e29 years, 39.7% for those
30e39 years, 50.2% for those 40e49 years, 71.3% for those
50e59 years, 82.9% for those 60e64 years.7 Some form of
sexual dysfunction is experienced by as many as 45% of women
in their lifetime.1 Also, prevalence of this condition may vary
depending on the adopted criteria.
Hypoactive sexual desire disorder (HSDD) is considered a
sexual dysfunction and is characterized as a lack or absence of
sexual fantasies and a desire for sexual activity, as judged by a
clinician. Personal distress or interpersonal difﬁculties is an
essential condition for diagnosis of sexual dysfunction according
to the criteria of Diagnostic and Statistical Manual of Mental
Disorders (DSM)-IV-TR and America Foundation of Urologic
Disease (AFUD).8,9 The DSM-V, published in May of 2013,
seeks to overcome the validity problems of a linear model of
sexual response.10 Female hypoactive desire dysfunction and fe-
male arousal dysfunction were merged into a single syndrome
called sexual interest/arousal disorder in DSM-V.11 Female sex-
ual interest/arousal disorder (FSIAD) is deﬁned as a “lack of, or
signiﬁcantly reduced, sexual interest/arousal,” manifesting as at
least three of the following symptoms: no or little interest in
sexual activity, no or few sexual thoughts, no or few attempts to
initiate sexual activity or respond to partner’s initiation, no or
little sexual pleasure/excitement in 75e100% of sexual experi-
ences, no or little sexual interest in internal or external erotic
stimuli, and no or few genital/nongenital sensations in
75e100% of sexual experiences.12
Expert committee of the Third International Consultation on
Sexual Medicine had emphasized the importance of measuring
distress in FSD and HSDD. They recommended using a vali-
dated measure for sexual distress in clinical trials in FSD as a
primary end point. This created the need for a validated measure
of FSD. Validated patient reported outcome measures for the
assessment of distress in FSD include the Sexual Satisfaction Scale
for Women, the Sexual Desire and Relationship Distress Scale,
the Female Sexual Distress Scale (FSDS), and the Female Sexual
Distress Scale-Revised (FSDS-R). As the result of the efforts of
AFUD to create a validated measure, the FSDS was developed.13
FSDS become the most extensively validated and widely used
scale for assessing sexuality-related distress in women. In 2008, a
revised version of the FSDS—the FSDS-R—was developed with
the addition of a 13th item, offering an increased sensitivitye
speciﬁcity proﬁle of the tool. FSDS-R demonstrated good
discriminant validity, high testeretest reliability, and a high de-
gree of internal consistency in measuring sexually related personal
distress in women with HSDD.14,15 Also the original FSDS and
revised FSDS are widely accepted and translated into different
languages and validated in various cultures and populations.14e19
Also, the translated forms are demonstrating strong internal
consistency, reliability, and validity.17e20 There is a lack of and aneed for a validated instrument for measuring sexuality-related
distress in women in Turkey.AIMS
The purposes of the study were to develop a Turkish version
of the FSDS-R, to evaluate its psychometric reliability and val-
idity, and to estimate the optimal cutoff score that corresponds
best to the clinical diagnosis of sexual dysfunction. The sec-
ondary objective was to analyze correlation with commonly
assessed domains of female sexual functioning.METHODS
Study Population and Design
This 2-week prospective methodological study was carried out
at the urogynecology unit of the Bezmialem Vakif University,
Istanbul, Turkey, between January 2015 and May 2015. The
study was approved by the institutional ethics committee. All
subjects were invited to the clinic through direct face-to-face
interview and telephone survey by medical students. They were
asked to come to clinic and interview with a clinician for this
study.
Eligibility criteria for inclusion into the study were to be 18
years or older, married, sexually active, and able to read, speak,
and understand Turkish. Exclusion criteria were pregnancy or
within 3 months postpartum, history of depression or other
mental disorders, severe chronic diseases (diabetes mellitus, car-
diovascular diseases, and liver and renal failure), psychoactive
substance addiction, alcohol abuse, obesity (body mass index
>30 kg/m2), history of major gynecological operations (hyster-
ectomy, oophorectomy, or mastectomy), and use of medications
affecting sexual function (antipsychotics, antihypertensives,
antidepressants, antihistamines, benzodiazepines, or oral contra-
ceptives). Of the 362 women invited to participate in the study,
66 women refused to participate, with refusal rates of 18.7%. Of
the remaining 296, 48 (16.2%) women were excluded from the
study according to exclusion criteria, resulting in a ﬁnal sample of
248 women.
Study protocol was brieﬂy explained to all women who agreed
to participate. After the study protocol was explained and written
informed consent was obtained, all eligible volunteers were asked
to complete self-administered questionnaires in a private room.
One of the authors was available when participants needed
further explanation about the questions. After completion of the
questionnaires, a standard medical evaluation form was used to
assess participants, and the DSM-V criteria were used for diag-
nosing FSD by two gynecologist. Based on the evaluation of
participants according to DSM-V criteria, women were assigned
to either FSIAD, other FSD, or the healthy control group. A
second survey was conducted with face-to-face interview after 2
weeks for testeretest reliability.Sex Med 2016;4:e43ee50
Turkish Version FSDS-R e45Linguistic Validation
The process to develop a Turkish version of the tool that was
equivalent to the one used for the original English version was
successfully completed. Linguistic validation was executed ac-
cording to linguistic validation process guidelines of MAPI
Institute.21 Validation process consisted of four steps including
forward translation, backward translation, pilot testing, and
cognitive debrieﬁng ﬁeld testing. One bilingual translator and
the ﬁrst author of the study independently translated the English
FSDS into Turkish. Then, the two translated drafts were
compared, and a ﬁrst version of the FSDS-R was developed in a
meeting with persons familiar with this issue. An independent
native English-speaking translator who was blind to the original
version of the scale translated the Turkish version back into
English. Finally, a translation committee, which consisted of the
ﬁrst author of the study, two independent translators and other
related authors, compared the backward-translated version with
the original English version. In this way, a second Turkish
version of the FSDS-R was created. The second version of the
Turkish FSDS-R was administered to n ¼ 20 nurses and to n ¼
10 women with known sexual distress to test the appropriateness,
acceptability, clarity, comprehensibility, and cultural relevancy.
No major problems were noted after pilot testing and face-to-face
interview. In the end, the ﬁnal version of the Turkish version of
Female Sexual Distress Scale-Revised (Tr-FSDS-R) was admin-
istered to all 248 women agreeing to participate in the ﬁeld
testing to ensure consistency of the translation and to enhance
cross-cultural comparability.FSDS-R
The FSDS-R is a patient-reported outcomes measure con-
sisting of 13 items assessing different aspects of sexual activity-
related distress in women.14 Items are scored on a ﬁve-point
Likert-type scale as never (0), rarely (1), occasionally (2),
frequently (3), or always (4). A total score, ranging from 0 to 52,
can be computed by adding all 13 item scores. Higher scores
indicate higher levels of sexual distress. The original version of
the FSDS-R demonstrated acceptable scale reliability with
Cronbach’s alpha values ranging from a ¼ 0.87 to a ¼ 0.93 and
high testeretest reliability (intraclass correlation coefﬁcient
[ICC] ranging from r ¼ 0.74 to r ¼ 0.86).14 It was successfully
cross-validated, and a diagnostic cutoff score of >11 was shown
to be highly effective in discriminating between women with
HSDD and other FSD and those without FSD.14,15 Uni-
dimensional structure of the FSDS-R was conﬁrmed by conﬁr-
matory factor analysis.FSFI
The second questionnaire was the Female Sexual Function
Index (FSFI), which enables the evaluation of the key dimensions
of female sexual function through its six domain structures:
desire, subjective arousal, lubrication, orgasm, satisfaction, and
pain.22 Higher scores indicate better sexual function. A totalSex Med 2016;4:e43ee50FSFI score under 26.55 indicates low sexual function, with
domain scores below 3.6 signifying abnormal function in the
respective areas.23,24 Furthermore, it has been shown to be a
reliable and validated measure of female sexual function when
used among the Turkish population.25Statistical Analysis
Reliability of the Tr-FSDS-R was assessed by internal consis-
tency and testeretest reliability. Alpha coefﬁcients (a) were used
as an indicator of internal consistency. A Cronbach alpha coef-
ﬁcient of 0.70 was considered to indicate acceptable reli-
ability.15 Testeretest reliability over a 2-week period was
estimated using ICCs. ICC values of 0.21e0.40 representing
poor to fair agreement, 0.41e0.60 moderate agreement,
0.61e0.80 good agreement, and >0.80 excellent agreement
between the two assessments.
Single unrotated principal component factor analysis was
conducted for all 13 questionnaire items to evaluate the factor
structure and construct validity of the Tr-FSDS-R. To determine
the optimal cutoff values of the Tr-FSDS-R to discriminate be-
tween participants without sexual distress and with sexual distress
due to low sexual interest/arousal or other sexual dysfunction, and
healthy women without sexual distress, a receiver operating
characteristic (ROC) curve was used. An area under curve (AUC)
of 0.5 indicates the inability of the measure to discriminate be-
tween sub-groups of the participants, whereas an AUC of 1.0
represents perfect discriminant validity.26 Discriminant validity
was assessed by comparing mean scores of the FSD and control
groups in a between-groups analysis of variance (ANOVA). It was
supposed that women with lower sexual functioning suffered from
more sexual distress.4,27 Therefore, correlation analysis conducted
between the FSDS-R total score, the FSFI subscale, and total score
was examined for convergent validity.
All the statistical analyses in this study were performed by
SPSS version 21.0 (IBM Corp, Armonk, NY, USA) statistical
software. Distribution of data was assessed with histogram
analysis and KruskaleWallis test. One-way ANOVA was used
for comparisons of continuous variables. Chi-square test was
used to compare the proportion of categorical variables. A P value
of <.05 was considered signiﬁcant for all tests.RESULTS
Of the 248 participants, 95 women were included in the
FSIAD group and 25 were included in the other FSD group. The
ﬁnal healthy control group comprised of 128 women. The mean
age for women with FSIAD, women with other types of FSD,
and healthy women was 35.8, 37.4, and 32.3 years, respectively.
Women with FSD were signiﬁcantly older than healthy controls.
Also, the mean age of women with other FSD was signiﬁcantly
higher than women with low sexual interest or arousal. Sample
characteristics, demographic data, and FSFI scores are presented
in Table 1. Consistently, ages of women, marital length, and age
Table 1. Baseline Characteristics, Female Sexual Function Index (FSFI) Total and Subdomain Scores of Sample with Sexual Dysfunction or
with Normal Sexual Function
FSIAD Other FSD No FSD
PN ¼ 95 N ¼ 25 N ¼ 128
Age, years (mean ± SD) 35.8 ± 6.6 37.4 ± 6.5 32.3 ± 4.5 <.0001
Age of partner, years (mean ± SD) 37.5 ± 6.9 39.4 ± 6.4 34 ± 5.8 <.0001
Marital length, years (mean ± SD) 10.8 ± 6.4 12.4 þ 6.3 7.4 ± 4.9 <.0001
BMI (mean ± SD) 26.6 ± 4.5 26.3 þ 5.1 27.6 ± 4.4 .4
Family income monthly, N (%)
< $200 7 (7.4) 3 (12) 5 (3.9) .8
$200e$1,000 10 (10.5) 7 (28) 18 (14.1)
>$1,000 78 (82.1) 15 (60) 105 (82)
Educational level, N (%)
Primary 46 (48.4) 21 (84) 21 (16.4) .001
High school 12 (12.6) - 19 (14.8)
Graduate 37 (38.9) 4 (16) 88 (68.8)
Infertility, N (%) 9 (9.5) 3 (12) 12 (9.4) .9
Nulliparity, N (%) 14 (14.7) 3 (12) 40 (31.3) .006
Occupational status
Housewife 48 (50.5) 20 (80) 28 (21.9) <.0001
Employee 47 (49.5) 5 (20) 100 (78.1)
FSFI score (mean ± SD) 17.9 ± 3.4 22.7 ± 2.7 24.4 ± 6.0 <.0001
Desire 2.2 ± 0.7 3.3 ± 0.8 3.5 ± 1.5 <.0001
Arousal 2.4 þ 0.6 3.9 ± 0.5 3.9 ± 1.3 <.0001
Lubrication 3.2 þ 0.6 4.0 ± 0.7 3.9 ± 0.8 <.0001
Orgasm 3.0 þ 0.7 3.7 ± 0.6 4.3 ± 1.0 <.0001
Satisfaction 2.6 þ 0.7 4.0 ± 0.9 4.1 ± 1.4 <.0001
Pain 3.6 þ 1.2 4.3 ± 0.9 4.5 ± 1.1 .001
Bolding indicates statistical signiﬁcance.
BMI ¼ body mass index; FSD ¼ female sexual dysfunction; FSIAD ¼ female sexual interest/arousal disorder; SD ¼ standard deviation.
Table 2. Discriminant Capability of the Turkish Version of the
Female Sexual Distress Scale-Revised (Tr-FSDS-R) at Cutoff Score
11.5 in Women with FSIAD Compared with Normal Sexual Function
FSIAD
(mean ± SD)
Other FSD
(mean ± SD)
No FSD
(mean ± SD) P
value*N ¼ 95 N ¼ 25 N ¼ 138
Day 0 31.3 ± 10.9 26.2 ± 6.9 7.5 ± 6.3 <.0001*
Day 15 32.1 ± 11.8 28.2 ± 7.6 8.7 ± 7.5 <.0001*
ANOVA test with post hoc test; same superscript (*) means P < .05 for
each other within the same row.
FSDS-R ¼ Female Sexual Distress Scale-Revised; FSD ¼ female sexual
dysfunction; FSIAD ¼ female sexual interest/arousal disorder; SD ¼
standard deviation.
e46 Aydın et alof partners were signiﬁcantly different between groups. Most of
the patients in FSIAD and other FSD had primary school edu-
cation. In comparison, most of the women (68.8%) with no
sexual dysfunction had a graduate degree of education. In our
study, population women without FSD had higher educational
levels, higher employee, and low parity compared with women
with FSD.
Mean total scores for Tr-FSDS-R at days 0 and 15 for FSIAD,
FSD, and normal sexual function groups are presented in
Table 2. Tr-FSDS-R discriminated FSIAD and FSD subjects
from healthy women irrespective of the recall time, which was
conﬁrmed by one-way ANOVA between groups. Subjects with
FSIAD had the highest scores compared with the women with
and without FSD. Otherwise, covariant analysis did not show
any signiﬁcant effects for age, duration of marriage, partner’s age,
occupational status, and educational level across all three
assessments.
Tr-FSDS-R demonstrated excellent internal consistencies,
with Cronbach alpha of 0.98. Internal consistencies of the
FSDS-R across the two assessments points for the three groups ofwomen ranged from a ¼ 0.87 to a ¼ 0.99 (Table 3). For the
assessment of testeretest reliability, the FSDS was administrated
at baseline and 15 days after baseline. The ICC of stability over a
2-week period was 0.97. ICCs ranged from 0.92 to 0.94 for
baseline and day 15 for FSIAD, other FSD and no FSD groups
(Table 4).Sex Med 2016;4:e43ee50
Table 3. Internal Consistency (Cronbach alpha) of the Turkish
Version of the Female Sexual Distress Scale-Revised (Tr-FSDS-R)
FSIAD Other FSD No FSD
N ¼ 95 N ¼ 25 N ¼ 138
Day 0 0.96 0.97 0.87
Day 15 0.98 0.97 0.99
FSD ¼ female sexual dysfunction; FSIAD ¼ female sexual interest/arousal
disorder.
Turkish Version FSDS-R e47To evaluate the factor structure of the Turkish version of
FSDS-R, single unrotated principal component analysis was
conducted. Based on this analysis, a one-factor unidimensional
model was established, which explained 85.7% of the total
variance of the Tr-FSDS-R items (Table 5). All items clustered in
a predicted fashion had relatively high factor loadings, supporting
the factor validity of the Tr-FSDS-R.
Correlation analysis for convergent validity showed negative
and statistically signiﬁcant correlations between the FSDS-R and
the arousal, orgasm, and satisfaction FSFI domains (r ¼ 0.21,
r ¼ 0.41 and r ¼ 0.32, respectively). Correlation with
orgasm dimension of FSFI and FSDS-R was moderate (P < .01).
In addition, correlation analysis of all 13 items of FSDS-R with
total FSDS-R score demonstrated signiﬁcantly good correlation,
and Pearson correlation score ranges from 0.41 to 0.69 (P < .01)
(Table 6).
Discriminant ROC analysis Tr-FSDS-R total score demon-
strated that AUC for the total FSDS-R score was 0.92 (range
0.87e0.96) at baseline, conﬁrming the good discriminant
validity of the scale (Figure 1). The optimal cutoff score was
found to be >11.5 to provide optimal sensitivity (97.9%) and
speciﬁcity (83.2%). Sensitivity, speciﬁcity, false positive, and
false negative values for the determination of FSIAD with the
cutoff score >11.5 at day 0 and day 15 are presented in
Table 7.DISCUSSION
The prevalence of FSIAD was 38.3% in our study population
(collected by call), and prevalence of other FSD was 10.1%. Our
prevalence was compatible with previous studies that reported
the prevalence of FSD and was 47% in our Turkish female
population.6 When we use a cutoff score of 11.5 according to the
FSDS-R, the prevalence of female sexual distress were 12.5%Table 4. TesteRetest Reliability of the Turkish Version of FSDS-R
FSIAD
ICC (95% CI)
Day 0e15 0.94 (0.91e0.96)
CI ¼ conﬁdence interval; ICC ¼ intraclass correlation coefﬁcient; FSDS-R ¼
FSIAD ¼ female sexual interest/arousal disorder.
Sex Med 2016;4:e43ee50(n ¼ 16) for the healthy women (women with no FSD) in our
study population. However, the prevalence of sexual distress in
healthy women was reported as 22e24% in two U.S. national
probability samples.4,28 Self-reported sexual problems, mainly
HSDD, were identiﬁed in about 40% of the U.S. population.4
Sexual problems associated with personal distress were much
less common, although reported by approximately 12% of
women in the same study population. The differences in prev-
alence can be explained with cultural, educational, and social
differences. Socioeconomic and demographic variables such as
age, race, marital status, partner status, employment, and level of
education were independently and signiﬁcantly associated with
FSD. Sexual functional problems increased with age, but female
sexual distress problems were more common in middle-aged
women than in younger or older women.4 Our high prevalence
of FSIAD can be due to our middle-aged study population. Fe-
male sexual functions diminished with age; however, distressing
sexual problems were more common in middle-aged women than
in younger or older women.1 Other possible explanations are
still high rates of arranged marriages instead of love marriages
in Turkish family structure, low knowledge about sexuality,
and being ashamed of talking and discussing sexuality.29
Stephenson and Meston showed that low desire was associated
with increased distress only in low-intimacy relationships.30
In the original validation study, the authors suggested a
cutoff score of 11 for the discrimination between HSDD
patients and healthy individuals.14,17 In the Farsi version, the
research population characteristics were similar to our popula-
tion due to cultural proximity, reported the cutoff score of 10.5,
whereas a Polish version proposed a cutoff score of 13.17,19
Results of the ROC analysis further revealed an optimal sensi-
tivity/speciﬁcity proﬁle of the questionnaire with a cutoff score
of 11.5. Our results are comparable with the original study and
Farsi version.
The Tr-FSDS-R was also highly reproducible across the
2-week interval, with higher ICC values in FSD and healthy
women. Reproducibility of this tool after a week and even after a
4-week interval had been reported in the original validation study
and other linguistic validation studies. The highest ICC being
found between day 7 to day 28 in original validation studies and
linguistic validation studies of the FSDS-R (Polish and
Farsi).17,19 The time interval between the two administrations of
measurements generally affect the ICC. It is generally accepted
that a very short time interval makes the carryover effects due toOther FSD No FSD
ICC (95% CI) ICC (95% CI)
0.92 (0.84e0.96) 0.92 (0.89e0.94)
Female Sexual Distress Scale-Revised; FSD ¼ female sexual dysfunction;
Table 5. Single Unrotated Principal Component Analysis of the
Turkish Version of the Female Sexual Distress Scale-Revised
(Tr-FSDS-R)
Item Factor 1
Distressed about your sex life 0.91
Unhappy about your sexual relationship 0.91
Guilty about sexual difﬁculties 0.94
Frustrated by your sexual problems 0.92
Stressed about sex 0.93
Inferior because of sexual problems 0.93
Worried about sex 0.94
Sexually inadequate 0.92
Regrets about your sexuality 0.94
Embarrassed about sexual problems 0.91
Dissatisﬁed with your sex life 0.92
Angry about your sex life 0.93
Bothered by low sexual desire 0.90
Eigenvalue 11.1
% of explained variance 85.7%
e48 Aydın et almemory, practice, or mood more likely, whereas a longer interval
increases the chances that a change in status could occur.31 Ac-
cording to this argument, we performed the testeretest reliability
for the stability of the FSDS-R in a 2-week interval.
In our study population, women with female sexual interest/
arousal disorder reported the highest levels of sexual distress
compared with the other FSD types and healthy controls.
Discriminant validity analysis of our results showed that
Tr-FSDS-R was able to differentiate between female sexual in-
terest/arousal disorder and other types of sexual dysfunction withTable 6. Pearson Correlation Coefﬁcients Between FSDS-R Items and
Total FSDS-R Total FSFI
FSFI domains
Desire Aro
Item 1 0.58** 0.26** 0.30** 0
Item 2 0.50** 0.42** 0.42** 0
Item 3 0.55** 0.31** 0.28** 0
Item 4 0.53** 0.30** 0.31** 0
Item 5 0.60** 0.30** 0.29** 0
Item 6 0.48** 0.30** 0.29** 0
Item 7 0.50** 0.35** 0.30** 0
Item 8 0.51** 0.20* 0.22* 0
Item 9 0.44** 0.22* 0.23** 0
Item 10 0.60** 0.31** 0.34** 0
Item 11 0.69** 0.19* 0.23** 0
Item 12 0.65** 0.25** 0.25** 0
Item 13 0.41** 0.28** 0.30** 0
Total FSDS-R 1 0.19* 0.02 0
*P < .05; **P < .01.
FSDS-R ¼ Female Sexual Distress Scale-Revised; FSFI ¼ Female Sexual Functnormal sexual functions successfully. Also consistent with pre-
vious reports and linguistic validation studies, sexually healthy
women reported signiﬁcantly lower FSDS-R scores compared
with women suffering from low sexual interest/arousal or from
any other type of FSD.14,16,17
Analysis of construct validity was carried out to test whether
the Derogatis’s original one-factor model could be replicated in
our present sample.14 Factor analysis stated the previously sug-
gested one-factor model solution also produced a perfect ﬁt in
our Turkish sample.14,17 Similar results were presented in the
Polish and Farsi validation study and showed one-factor solution
to provide best ﬁt to data.17,19 The 13 items of the scale loaded
consistently on the same underlying factor with stable one-
dimensional structure.LIMITATIONS
Finally, this study had the following limitations. First, study
sample was small and not fully representative of all Turkish
women, although it was large enough to draw reasonable con-
clusions. Second, study sample was homogenous: mostly middle-
aged, mostly premenopausal women who were not taking oral
contraceptives or hormonal replacement and monogamic. The
lack of use of the depression survey was another weak point of
this study, but we excluded the women with known depression
and anxiety or who use antidepressants. Data about sexual ac-
tivity such as caressing, foreplay, vaginal intercourse, masturba-
tion, vaginal, anal or oral intercourse, and frequency of sexual
activity would contribute to the results. Recruitment of partici-
pants outside the hospital, not from admission to hospital, is the
major strength of the study. After all these limitations, theFSDS-R Total Scores, FSFI Total Scores, and FSFI Domain Scores
usal Lubrication Orgasm Satisfaction Pain
.40** 0.22* 0.19* 0.23** 0.07
.50** 0.38** 0.36** 0.30** 0.0
.40** 0.23** 0.24** 0.21* 0.04
.42** 0.29** 0.22* 0.21* 0.03
.40** 0.26** 0.20* 0.26** 0.06
.38** 0.26** 0.26** 0.20* 0.03
.46** 0.30** 0.26** 0.22* 0.02
.29** 0.14 0.16 0.08 0.02
.32** 0.20* 0.20* 0.11 0.02
.35** 0.31** 0.21* 0.29** 0.03
.28** 0.15 0.02 0.16 0.02
.30** 0.23** 0.15 0.21* 0.04
.37** 0.24** 0.21* 0.13** 0.02
.21* 0.09 0.41** 0.32** 0.13
ion Index.
Sex Med 2016;4:e43ee50
Figure 1. Receiver operating characteristic (ROC) curve for total
score of the Turkish version of the Female Sexual Distress Scale-
Revised at day 0.
Turkish Version FSDS-R e49ﬁndings are in agreement with the validation study of the original
FSDS-R.CONCLUSIONS
The results of this study are that the Turkish version of
FSDS-R is a valid, reliable tool with well-discriminative and
psychometric validity for the use in Turkish female population
and can be used as a screening questionnaire for females with
sexual interest/arousal disorder. The score of 11.5 was pro-
posed as a cutoff to detect the presence of sexually related per-
sonal distress in Turkish women with FSD. The development of
the Turkish version of FSDS-R will allow us to measure sexual
function related to sexual distress and affect on women’s quality
of life in the Turkish speaking population. This will enhance our
knowledge of how and to what extent cultural, social differences,
family structure, and religious beliefs affect sexual distress that is
considered as an obligation for the deﬁnition of sexual
dysfunction.Table 7. Discriminant Capability of the Turkish Version of the
Female Sexual Distress Scale-Revised (Tr-FSDS-R) at Cutoff Score
11.5 in Women with FSIAD Compared with Normal Sexual Function
Sensitivity
(%)
Speciﬁcity
(%)
False
positives
(%)
False
negatives
(%)
Day 0 98.3 87.5 0.8 6.5
Day 15 97.5 77.3 1.2 11.7
FSIAD ¼ female sexual interest/arousal disorder.
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